Physician profile
Kenneth D Westover
NPI 1629261524
$24,000.67
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,772 · 2021: $2,750 · 2022: $123 · 2023: $11K · 2024: $7,616.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $3,275 · Food and Beverage: $1,011.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $14,070.00 |
| Travel and Lodging | $3,274.80 |
| Food and Beverage | $1,010.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $10,739.76 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $6,163.12 | 2022-2024 | Tagrisso |
| Sanofi US Services INC. | $2,772.00 | 2020 | |
| Amgen INC. | $2,750.00 | 2021 | |
| Promega Corporation | $1,336.54 | 2024 | |
| Elekta, INC. | $239.25 | 2024 | Elekta Medical Linear Accelerator |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Westover listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.